PUBLICATIONS INTERNATIONALES 2010 1 Afonso PV

PUBLICATIONS INTERNATIONALES 2010
1
Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, Gessain
A, Bangham CR, Dubreuil G, Plumelle Y, Hermine O, Estaquier J, Mahieux R
(2010) Highly active antiretroviral treatment against STLV-1 infection combining
reverse transcriptase and HDAC inhibitors. Blood 116: 3802-3808
2
Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, Habrand JL,
Thiesse P, Cuilliere JC, Bernier V, Ben Hassel M, Frappaz D, Baranzelli MC,
Bouffet E (2010) Pattern of relapse and outcome of non-metastatic germinoma
patients treated with chemotherapy and limited field radiation: the SFOP
experience. Neuro Oncol 12: 1318-1325
3
Alexandre J, Ray-Coquard I, Selle F, Floquet A, Cottu P, Weber B, Falandry C,
Lebrun D, Pujade-Lauraine E (2010) Mucinous advanced epithelial ovarian
carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based
chemotherapy, the GINECO experience. Ann Oncol 21: 2377-2381
4
Alfano L, Guida T, Provitera L, Vecchio G, Billaud M, Santoro M, Carlomagno F
(2010) RET is a heat shock protein 90 (HSP90) client protein and is knocked
down upon HSP90 pharmacological block. J Clin Endocrinol Metab 95: 35523557
5
Annereau JP, Brel V, Dumontet C, Guminski Y, Imbert T, Broussas M, Vispe S,
Breand S, Guilbaud N, Barret JM, Bailly C (2010) A fluorescent biomarker of the
polyamine transport system to select patients with AML for F14512 treatment.
Leuk Res 34: 1383-1389
6
Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A (2010) TWISTing an
embryonic transcription factor into an oncoprotein. Oncogene 29: 3173-3184
7
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL,
Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G,
Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian
S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo
P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH,
Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL, Thomassen M,
Gerdes AM, Sunde L, Cruger D, Birk JU, Caligo M, Friedman E, Kaufman B,
Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernstrom H, Lindblom
A, Rantala J, Stenmark-Askmalm M, Melin B, Nathanson K, Domchek S,
Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Duran M, Tejada MI,
Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB,
van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst
F, Rookus M, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F,
Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ,
Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S, Godwin AK, StoppaLyonnet D, de PA, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D,
Hardouin A, Berthet P, Faivre L, Loustalot C, Noguchi T, Sobol H, Rouleau E,
Nogues C, Frenay M, Venat-Bouvet L, Hopper JL, Daly MB, Terry MB, John
EM, Buys SS, Yassin Y, Miron A, Goldgar D, Singer CF, Dressler AC,
Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jonson L, Agnarsson BA,
Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC,
Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna
M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ,
Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C,
Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R,
Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K,
Schonbuchner I, Caldes T, de la Hoya M, Aittomaki K, Nevanlinna H, Simard J,
Spurdle AB, Holland H, Chen X, Platte R, Chenevix-Trench G, Easton DF
(2010) Common breast cancer susceptibility alleles and the risk of breast cancer
for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Cancer Res 70: 9742-9754
8
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova
OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale
D, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L,
Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S,
Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P, Hogervorst
FB, Rookus MA, Jager A, van den OA, Hoogerbrugge N, van der Luijt RB,
Meijers-Heijboer H, Gomez Garcia EB, Devilee P, Vreeswijk MP, Lubinski J,
Jakubowska A, Gronwald J, Huzarski T, Byrski T, Gorski B, Cybulski C, Spurdle
AB, Holland H, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly
MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, PreislerAdams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL,
Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF,
Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL,
Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci
C, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M,
Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de
la HM, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L,
Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ,
Gayther SA, Phelan C, Narod S, Szabo CI, Benitez J, Osorio A, Nevanlinna H,
Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M,
Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade
O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG,
Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H, Severi G,
Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D,
Fountzilas G, Fasching PA, Beckmann MW, Dos SS, I, Peto J, Lambrechts D,
Paridaens R, Rudiger T, Forsti A, Winqvist R, Pylkas K, Diasio RB, Lee AM,
2
Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K,
Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ (2010) A
locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is
associated with hormone receptor-negative breast cancer in the general
population. Nat Genet 42: 885-892
9 Arnaud O, Koubeissi A, Ettouati L, Terreux R, Alame G, Grenot C, Dumontet C,
Di PA, Paris J, Falson P (2010) Potent and fully noncompetitive peptidomimetic
inhibitor of multidrug resistance P-glycoprotein. J Med Chem 53: 6720-6729
10
Autier P, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson
JG, Olafsson JH, Byrnes GB, Hery C, Dore JF, Boniol M (2010) Autier et al.
Respond to "A Sunbed Epidemic?". Am J Epidemiol
11
Bachelard-Cascales E, Chapellier M, Delay E, Pochon G, Voeltzel T, Puisieux A,
Caron dF, Maguer-Satta V (2010) The CD10 enzyme is a key player to identify
and regulate human mammary stem cells. Stem Cells 28: 1081-1088
12
Banneau G, Guedj M, Macgrogan G, de M, I, Velasco V, Schiappa R, Bonadona
V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de
Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M (2010) Molecular apocrine
differentiation is a common feature of breast cancer in patients with germline
PTEN mutations. Breast Cancer Res 12: R63
13
Bastid J, Bouchet BP, Ciancia C, Pourchet J, Audoynaud C, Grelier G, Puisieux
A, Ansieau S (2010) The SNAIL family member SCRATCH1 is not expressed in
human tumors. Oncol Rep 23: 523-529
14
Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O,
Pallusseau L, Carnin C, Laine K, Schlama A, Thiebaut A, Patru MC, Bauchet F,
Lionnet M, Wager M, Faillot T, Taillandier L, Figarella-Branger D, Capelle L,
Loiseau H, Frappaz D, Campello C, Kerr C, Duffau H, Reme-Saumon M,
Tretarre B, Daures JP, Henin D, Labrousse F, Menei P, Honnorat J (2010)
Oncological patterns of care and outcome for 952 patients with newly diagnosed
glioblastoma in 2004. Neuro Oncol
15
Belbaraka R, Tredan O, Ray-Coquard I, Chvetzoff G, Bajard A, Perol D, Ismaili
N, Ismaili M, Errihani H, Bachelot T, Rebattu P (2010) Factors of interrupting
chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer. BMC Res
Notes 3: 164
16
Benjamin RS, Schoffski P, Hartmann JT, Van Oosterom A, Bui BN, Duyster J,
Schuetze S, Blay JY, Reichardt P, Rosen LS, Skubitz K, McCoy S, Sun YN,
Stepan DE, Baker L (2010) Efficacy and safety of motesanib, an oral inhibitor of
VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant
gastrointestinal stromal tumors. Cancer Chemother Pharmacol
3
17
Berthier-Vergnes O, Kharbili ME, de la Fouchardiere A, Pointecouteau T,
Verrando P, Wierinckx A, Lachuer J, Le NF, Lamartine J (2010) Gene expression
profiles of human melanoma cells with different invasive potential reveal
TSPAN8 as a novel mediator of invasion. Br J Cancer
18
Bertrand A, Marec-Berard P, Raverot G, Trouillas J, Marabelle A (2010)
Cabergoline therapy of paraneoplastic Cushing syndrome in children. Pediatr
Blood Cancer 55: 589-590
19
Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G,
Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J,
Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D,
Fert V, Birnbaum D, Viens P (2010) Gene expression profile predicts outcome
after anthracycline-based adjuvant chemotherapy in early breast cancer. Breast
Cancer Res Treat
20
Billaud M, Viollet B (2010) Close encounters of a novel kind: A multi-targeted
cancer drug meets a metabolic sensor. Cancer Biol Ther 10:
21
Blay JY (2010) Pharmacological management of gastrointestinal stromal tumours:
an update on the role of sunitinib. Ann Oncol 21: 208-215
22
Blay JY (2010) Updating progress in sarcoma therapy with mTOR inhibitors. Ann
Oncol
23
Blay JY, von Mehren M, Blackstein ME (2010) Perspective on updated treatment
guidelines for patients with gastrointestinal stromal tumors. Cancer 116: 51265137
24
Bodard AG, Paris M, Salino S, Fortin T (2010) Evaluation of two noninvasive
repositioning systems for computer-assisted oral implant surgery in oral cancer
patients. Int J Prosthodont 23: 463-468
25
Boisseau N, Burde A, Bachmann P, Senesse P, Hebuterne X (2010) A telephonelinked computer system for home enteral nutrition. J Telemed Telecare 16: 363367
26
Boivin A, Currie K, Fervers B, Gracia J, James M, Marshall C, Sakala C, Sanger
S, Strid J, Thomas V, van der WT, Grol R, Burgers J (2010) Patient and public
involvement in clinical guidelines: international experiences and future
perspectives. Qual Saf Health Care 19: e22
27
Bonaiti B, Bonadona V, Perdry H, Andrieu N, Bonaiti-Pellie C (2010) Estimating
penetrance from multiple case families with predisposing mutations: extension of
the 'genotype-restricted likelihood' (GRL) method. Eur J Hum Genet
28
Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG,
Raquin MA, Rousseau R, Combaret V, Benard J, Tauszig-Delamasure S, Mehlen
4
P (2010) Neurotrophin-3 production promotes human neuroblastoma cell survival
by inhibiting TrkC-induced apoptosis. J Clin Invest 120: 850-858
29
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting, and evaluation
in health care. Prev Med 51: 421-424
30
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting and evaluation in
health care. J Clin Epidemiol 63: 1308-1311
31
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L
(2010) AGREE II: Advancing guideline development, reporting and evaluation in
health care. CMAJ 182: E839-E842
32
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part
1: performance, usefulness and areas for improvement. CMAJ 182: 1045-1052
33
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers
B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part
2: assessment of validity of items and tools to support application. CMAJ 182:
E472-E478
34
Buiret G, Combe C, Favrel V, Pommier P, Martin L, Ecochard R, Fayette J,
Tartas S, Ramade A, Ceruse P (2010) A retrospective, multicenter study of the
tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of
squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 77:
430-437
35
Butturini A, Frappaz D (2010) The challenges of high-dose chemotherapy in CNS
tumors. Pediatr Blood Cancer 54: 652-653
36
Campone M, Juin P, Andre F, Bachelot T (2010) Resistance to HER2 inhibitors:
Is addition better than substitution? Rationale for the hypothetical concept of drug
sedimentation. Crit Rev Oncol Hematol
37
Carrabin N, Mithieux F, Meeus P, Tredan O, Guastalla JP, Bachelot T, Labidi SI,
Treilleux I, Rivoire M, Ray-Coquard I (2010) Hyperthermic intraperitoneal
chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC
ovarian cancer. Bull Cancer 97: E23-E32
5
38
Casali PG, Blay JY (2010) Gastrointestinal stromal tumours: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 Suppl
5: v98-102
39
Casali PG, Blay JY (2010) Soft tissue sarcomas: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 Suppl 5: v198v203
40
Cassier PA, Blay JY (2010) Imatinib mesylate for the treatment of gastrointestinal
stromal tumor. Expert Rev Anticancer Ther 10: 623-634
41
Cassier PA, Blay JY (2010) Molecular response prediction in gastrointestinal
stromal tumors. Target Oncol 5: 29-37
42
Cassier PA, Ducimetiere F, Lurkin A, Ranchere-Vince D, Scoazec JY, Bringuier
PP, Decouvelaere AV, Meeus P, Cellier D, Blay JY, Ray-Coquard I (2010) A
prospective epidemiological study of new incident GISTs during two consecutive
years in Rhone Alpes region: incidence and molecular distribution of GIST in a
European region. Br J Cancer 103: 165-170
43
Castets M, Mehlen P (2010) Netrin-1 role in angiogenesis: To be or not to be a
pro-angiogenic factor? Cell Cycle 9:
44
Chargui J, Combaret V, Scaglione V, Iacono I, Peri V, Valteau-Couanet D,
Dubrel M, Angevin E, Puisieux A, Romagne F, Bergeron C (2010) Bromohydrin
pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from
patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells.
J Immunother 33: 591-598
45
Charles J, Di DJ, Salameire D, Bendriss-Vermare N, Aspord C, Muhammad R,
Lefebvre C, Plumas J, Leccia MT, Chaperot L (2010) Characterization of
circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic
cell recruitment to the tumor. J Invest Dermatol 130: 1646-1656
46
Chatagnon A, Ballestar E, Esteller M, Dante R (2010) A role for methyl-CpG
binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1
gene. PLoS One 5 (3): e9665
47
Chenot J, Melodelima D, N'djin WA, Souchon R, Rivoire M, Chapelon JY (2010)
Intra-operative ultrasound hand-held strain imaging for the visualization of
ablations produced in the liver with a toroidal HIFU transducer: first in vivo
results. Phys Med Biol 55: 3131-3144
48
Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de
Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, VinceRanchere D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A
(2010) Validated prediction of clinical outcome in sarcomas and multiple types of
6
cancer on the basis of a gene expression signature related to genome complexity.
Nat Med 16: 781-787
49
Cimarelli S, Lachenal F, Ricard F, Chassagne-Clement C, Heudel PE, Janody P,
Sebban C (2010) A case of advanced non-Hodgkin's lymphoma involving the
prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging.
Clin Nucl Med 35: 425-427
50
Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G, Kaltenbach S,
Yakouben K, Mazingue F, Robert A, Boutard P, Plantaz D, Rohrlich P, van
Vlierberghe P, Preudhomme C, Otten J, Speleman F, Dastugue N, Suciu S,
Benoit Y, Bertrand Y, Cave H (2010) NOTCH1 and FBXW7 mutations have a
favorable impact on early response to treatment, but not on outcome, in children
with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials
58881 and 58951. Leukemia 24: 2023-2031
51
Cohen S, Jordheim LP, Megherbi M, Dumontet C, Guitton J (2010) Liquid
chromatographic methods for the determination of endogenous nucleotides and
nucleotide analogs used in cancer therapy: a review. J Chromatogr B Analyt
Technol Biomed Life Sci 878: 1912-1928
52
Coiffier B, Thieblemont C, Van den NE, Lepeu G, Plantier I, Castaigne S, Lefort
S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferme C, Tilly H
(2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized
study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL
patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 116:
2040-2045
53
Cortes J, Vahdat L, Blum JL, Twelves C, Campone M, Roche H, Bachelot T,
Awada A, Paridaens R, Goncalves A, Shuster DE, Wanders J, Fang F, Gurnani R,
Richmond E, Cole PE, Ashworth S, Allison MA (2010) Phase II study of the
halichondrin B analog eribulin mesylate in patients with locally advanced or
metastatic breast cancer previously treated with an anthracycline, a taxane, and
capecitabine. J Clin Oncol 28: 3922-3928
54
Cosset E, Hamdan G, Jeanpierre S, Voeltzel T, Sagorny K, Hayette S, Mahon FX,
Dumontet C, Puisieux A, Nicolini FE, Maguer-Satta V (2010) Deregulation of
TWIST-1 in the CD34+ compartment represents a novel prognostic factor in
chronic myeloid leukemia (CML). Blood
55
Cutuli B, Le Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B,
Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F,
Romestaing P, Delva C, Comet B, Belkacemi Y (2010) Male breast cancer.
Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev
Oncol Hematol 73: 246-254
56
David M, Wannecq E, Descotes F, Jansen S, Deux B, Ribeiro J, Serre CM, Gres
S, Bendriss-Vermare N, Bollen M, Saez S, Aoki J, Saulnier-Blache JS, Clezardin
7
P, Peyruchaud O (2010) Cancer cell expression of autotaxin controls bone
metastasis formation in mouse through lysophosphatidic acid-dependent
activation of osteoclasts. PLoS One 5: e9741
57
de Brito C, Tomkowiak M, Ghittoni R, Caux C, Leverrier Y, Marvel J (2010)
CpG Promotes Cross-Presentation of Dead Cell-Associated Antigens by PreCD8{alpha}+ Dendritic Dells. J Immunol
58
de la Fouchardière C, Négrier S, Labrosse H, Martel L, I, Desseigne F, Meeus P,
Tavan D, Petit-Laurent F, Rivoire M, Perol D, Carrie C (2010) Phase I study of
daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys 77: 409-413
59 de la Grange P, Gratadou L, Delord M, Dutertre M, Auboeuf D (2010) Splicing
factor and exon profiling across human tissues. Nucleic Acids Res 38: 2825-2838
60
Delay E, Sinna R, Chekaroua K, Delaporte T, Garson S, Toussoun G (2010)
Lipomodeling of Poland's syndrome: a new treatment of the thoracic deformity.
Aesthetic Plast Surg 34: 218-225
61
Desgranges FP, Steghens A, Mithieux F, Rosay H (2010) Potential risks of
thoracic epidural analgesia in hyperthermic intraperitoneal chemotherapy. J Surg
Oncol 101: 442
62
Domont J, Salas S, Lacroix L, Brouste V, Saulnier P, Terrier P, Ranchere D,
Neuville A, Leroux A, Guillou L, Sciot R, Collin F, Dufresne A, Blay JY, Le
Cesne A, Coindre JM, Bonvalot S, Benard J (2010) High frequency of betacatenin heterozygous mutations in extra-abdominal fibromatosis: a potential
molecular tool for disease management. Br J Cancer 102: 1032-1036
63
Dore JF, Boniol M, Telle-Lamberton M (2010) Re: Time trends in brain tumor
incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl
Cancer Inst 102: 741-742
64
Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J,
Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E,
Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE,
Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le ML, Lund E,
Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A,
Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M,
Ziegler RG, Cox DG (2010) PTGS2 and IL6 genetic variation and risk of breast
and prostate cancer: results from the Breast and Prostate Cancer Cohort
Consortium (BPC3). Carcinogenesis 31: 455-461
65
Dreux N, Marty M, Chibon F, Velasco V, Hostein I, Ranchere-Vince D, Terrier P,
Coindre JM (2010) Value and limitation of immunohistochemical expression of
HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol 23 :
1657-1666
8
66
du BA, Reuss A, Harter P, Pujade-Lauraine E, Ray-Coquard I, Pfisterer J (2010)
Potential role of lymphadenectomy in advanced ovarian cancer: a combined
exploratory analysis of three prospectively randomized phase III multicenter
trials. J Clin Oncol 28: 1733-1739
67
Dufresne A, Bertucci F, Penel N, Le Cesne A, Bui B, Tubiana-Hulin M, RayCoquard I, Cupissol D, Chevreau C, Perol D, Goncalves A, Jimenez M, Bringuier
PP, Blay JY (2010) Identification of biological factors predictive of response to
imatinib mesylate in aggressive fibromatosis. Br J Cancer 103: 482-485
68
Dumontet C, Jordan MA (2010) Microtubule-binding agents: a dynamic field of
cancer therapeutics. Nat Rev Drug Discov 9: 790-803
69
Dumontet C, Krajewska M, Treilleux I, Mackey JR, Martin M, Rupin M,
Lafanechere L, Reed JC (2010) BCIRG 001 molecular analysis: prognostic
factors in node-positive breast cancer patients receiving adjuvant chemotherapy.
Clin Cancer Res 16: 3988-3997
70
Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch
K, de la Grange P, Auboeuf D (2010) Estrogen regulation and physiopathologic
significance of alternative promoters in breast cancer. Cancer Res 70: 3760-3770
71
Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S,
Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D (2010) Exon-based
clustering of murine breast tumor transcriptomes reveals alternative exons whose
expression is associated with metastasis. Cancer Res 70: 896-905
72
Dutertre M, Sanchez G, De Cian MC, Barbier J, Dardenne E, Gratadou L,
Dujardin G, Le Jossic-Corcos C, Corcos L, Auboeuf D (2010) Cotranscriptional
exon skipping in the genotoxic stress response. Nat Struct Mol Biol 17: 13581366
73
Dutertre M, Vagner S, Auboeuf D (2010) Alternative splicing and breast cancer.
RNA Biol 7 (4): 403-411
74
Egevad L, Valdman A, Wiklund NP, Seve P, Dumontet C (2010) Beta-tubulin III
expression in prostate cancer. Scand J Urol Nephrol 44: 371-377
75
Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Meeus P,
Sunyach MP, Vaz G, Ray-Coquard I, Ranchere D, Decouvelaere AV, Alberti L,
Perol D, Blay JY (2010) Efficacy of trabectedin for advanced sarcomas in clinical
trials versus compassionate use programs: analysis of 92 patients treated in a
single institution. Anticancer Drugs 21: 113-119
76
Fayette J, Montella A, Chabaud S, Bachelot T, Pommier P, Girodet D, Racadot S,
Montbarbon X, Favier B, Zrounba P (2010) Paclitaxel is effective in relapsed
head and neck squamous cell carcinoma: a retrospective study of 66 patients at a
single institution. Anticancer Drugs 21: 553-558
9
77
Fervers B, Carretier J, Bataillard A (2010) Clinical practice guidelines. J Visc
Surg 147: e341-e349
78
Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B,
Feham N, Berger C, Garaud P, Calais G (2010) Concomitant chemoradiotherapy
using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-andneck cancer: results of GORTEC Phase II study. Int J Radiat Oncol Biol Phys 76:
154-163
79
Flechon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP (2010) Longterm oncological outcome after post-chemotherapy retroperitoneal lymph node
dissection in men with metastatic nonseminomatous germ cell tumour. BJU Int
106: 779-785
80
Fougere M, Gaudineau B, Barbier J, Guaddachi F, Feugeas JP, Auboeuf D,
Jauliac S (2010) NFAT3 transcription factor inhibits breast cancer cell motility
by targeting the Lipocalin 2 gene. Oncogene 29: 2292-2301
81
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segre AV,
McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM,
Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars M, Sobol H, Longy M, Frenay
M, GEMO SC, Hogervorst FB, Rookus MA, Collee JM, Hoogerbrugge N, van
Roozendaal KE, Piedmonte M, Rubinstein W, Nerenstone S, Van LL, Blank SV,
Caldes T, de la Hoya M, Nevanlinna H, Aittomaki K, Lazaro C, Blanco I, Arason
A, Johannsson OT, Barkardottir RB, Devilee P, Olopade OI, Neuhausen SL,
Wang X, Fredericksen ZS, Peterlongo P, Manoukian S, Barile M, Viel A, Radice
P, Phelan CM, Narod S, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL,
Glendon G, Ozcelik H, Toland AE, Montagna M, D'Andrea E, Friedman E,
Laitman Y, Borg A, Beattie M, Ramus SJ, Domchek SM, Nathanson KL,
Rebbeck T, Spurdle AB, Chen X, Holland H, John EM, Hopper JL, Buys SS,
Daly MB, Southey MC, Terry MB, Tung N, Overeem Hansen TV, Nielsen FC,
Greene MI, Mai PL, Osorio A, Duran M, Andres R, Benitez J, Weitzel JN,
Garber J, Hamann U, Peock S, Cook M, Oliver C, Frost D, Platte R, Evans DG,
Lalloo F, Eeles R, Izatt L, Walker L, Eason J, Barwell J, Godwin AK, Schmutzler
RK, Wappenschmidt B, Engert S, Arnold N, Gadzicki D, Dean M, Gold B, Klein
RJ, Couch FJ, Chenevix-Trench G, Easton DF, Daly MJ, Antoniou AC, Altshuler
DM, Offit K, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars
M, Sobol H, Longy M, Frenay M, Sinilnikova O, Barjhoux L, Giraud S, Leone
M, Mazoyer S, Stoppa-Lyonnet D, Gauthier-Villars M, Houdayer C, Moncoutier
V, Belotti M, de PA, Bressac-de-Paillerets B, Remenieras A, Byrde V, Caron O,
Lenoir G, Bignon YJ, Uhrhammer N, Lasset C, Bonadona V, Hardouin A,
Berthet P, Sobol H, Bourdon V, Noguchi T, Eisinger F, Coulet F, Colas C,
Soubrier F, Coupier I, Peyrat JP, Fournier J, Revillion F, Vennin P, Adenis C,
Rouleau E, Lidereau R, Demange L, Nogues C, Muller D, Fricker JP, Longy M,
Sevenet N, Toulas C, Guimbaud R, Gladieff L, Feillel V, Leroux D, Dreyfus H,
Rebischung C, Cassini C, Faivre L, Prieur F, Ferrer SF, Frenay M, Venat-Bouvet
L, Lynch HT, Hogervorst FB, Rookus MA, Collee JM, Hoogerbrugge N, van
10
Roozendaal KE, Hogervorst FB, Verhoef S, Verheus M, van 't Veer LJ, van
Leeuwen FE, Rookus MA, Collee M, van den Ouweland AM, Jager A, Hooning
MJ, Tilanus-Linthorst MM, Seynaeve C, van Asperen CJ, Wijnen JT, Vreeswijk
MP, Tollenaar RA, Devilee P, Ligtenberg MJ, Hoogerbrugge N, Ausems MG,
van der Luijt RB, Aalfs CM, van Os TA, Gille JJ, Waisfisz Q, Meijers-Heijboer
H, Gomez-Garcia EB, van Roozendaal CE, Blok MJ, Oosterwijk JC, van der
Hout AH, Mourits MJ, Vasen HF, Spurdle AB, Chenevix-Trench G (2010)
Common genetic variants and modification of penetrance of BRCA2-associated
breast cancer. PLoS Genet 6: e1001183
82
Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro
M, Dore JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC,
Katalinic A, Lucas R, Marghoob AA, Nolte S, Schuz J, Tucker MA, Volkmer B,
Breitbart E (2010) A nationwide population-based skin cancer screening in
Germany: proceedings of the first meeting of the International Task Force on
Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer
Epidemiol 34: 355-358
83
Gerard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M (2010) Influence of
Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic
Stem Cell Transplantation: Analysis with a PBPK Model. Pharm Res 27: 26022613
84
Ghayad SE, Cohen PA (2010) Inhibitors of the PI3K/Akt/mTOR pathway: new
hope for breast cancer patients. Recent Pat Anticancer Drug Discov 5: 29-57
85
Ghayad SE, Vendrell JA, Larbi SB, Dumontet C, Bieche I, Cohen PA (2010)
Endocrine resistance associated with activated ErbB system in breast cancer cells
is reversed by inhibiting MAPK or PI3K/Akt signaling pathways. Int J Cancer
126: 545-562
86
Ghesquieres H, Ferlay C, Sebban C, Perol D, Bosly A, Casasnovas O, Reman O,
Coiffier B, Tilly H, Morel P, Van den NE, Colin P, Haioun C, Biron P, Blay JY
(2010) Long-term follow-up of an age-adapted C5R protocol followed by
radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective
multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte
(GELA). Ann Oncol 21: 842-850
87
Giacchero D, Maire G, Nuin PA, Berthier F, Ebran N, Carlotti A, Celerier P,
Coindre JM, Esteve E, Fraitag S, Guillot B, Ranchere-Vince D, Saiag P, Terrier
P, Lacour JP, Pedeutour F (2010) No correlation between the molecular subtype
of COL1A1-PDGFB fusion gene and the clinico-histopathological features of
dermatofibrosarcoma protuberans. J Invest Dermatol 130: 904-907
88
Giard S, Chauvet MP, Penel N, Mignotte H, Martel P, Tunon dL, Gimbergues P,
Dessogne P, Classe JM, Fondrinier E, Marmousez T (2010) Feasibility of sentinel
lymph node biopsy in multiple unilateral synchronous breast cancer: results of a
11
French prospective multi-institutional study (IGASSU 0502). Ann Oncol 21:
1630-1635
89
Goldschneider D, Mehlen P (2010) Dependence receptors: a new paradigm in cell
signaling and cancer therapy. Oncogene 29: 1865-1882
90
Gouas DA, Shi H, Hautefeuille AH, Ortiz-Cuaran SL, Legros PC, Szymanska KJ,
Galy O, Egevad LA, Abedi-Ardekani B, Wiman KG, Hantz O, Caron dF, Chemin
IA, Hainaut PL (2010) Effects of the TP53 p.R249S mutant on proliferation and
clonogenic properties in human hepatocellular carcinoma cell lines: interaction
with hepatitis B virus X protein. Carcinogenesis 31: 1475-1482
91
Goutelle S, Larcher R, Padoin C, Mialou V, Bleyzac N (2010) Oral voriconazole
dose in children: one size does not fit all. Clin Infect Dis 51: 870
92
Gronchi A, Blay JY, Trent JC (2010) The role of high-dose imatinib in the
management of patients with gastrointestinal stromal tumor. Cancer 116: 18471858
93
Guilcher MA, Prevost B, Sunyach MP, Peiffert D, Maingon P, Thomas L,
Williaume D, Begue M, Lerouge D, Campion L, Mahe MA (2010) High-DoseRate Brachytherapy for Non-Small-Cell Lung Carcinoma: A Retrospective Study
of 226 Patients. Int J Radiat Oncol Biol Phys
94
Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C (2010) Tubulin
binding cofactor C (TBCC) suppresses tumor growth and enhances
chemosensitivity in human breast cancer cells. BMC Cancer 10: 135
95
Harrison MB, Legare F, Graham ID, Fervers B (2010) Adapting clinical practice
guidelines to local context and assessing barriers to their use. CMAJ 182: E78E84
96
Heritier S, Le Merrer M, Jaubert F, Bigorre M, Gillibert-Yvert M, de Court, Ziade
M, Bertrand Y, Carrie C, Chastagner P, Bost-Bru C, Leonard JC, Ouache M,
Boccon-Gibod L, Mary P, de Blic J, Pin I, Wendling D, Revillon Y, Houdoin V,
Forin V, Lepointe HD, Languepin J, Wagnon J, Epaud R, Fauroux B, Donadieu J
(2010) Retrospective French nationwide survey of childhood aggressive vascular
anomalies of bone, 1988-2009. Orphanet J Rare Dis 5: 3
97
Hery C, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson
JG, Olafsson JH, Boniol M, Byrnes GB, Dore JF, Autier P (2010) A melanoma
epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol 172: 762767
98
Heudel P, Biston MC, Fayette J, Ramade A, Gassa F, Pommier P (2010) Head
and neck sarcoma: report of a case treated by intensity-modulated radiation
therapy. Int J Clin Oncol 15: 305-309
12
99
Heudel P, Cimarelli S, Montella A, Bouteille C, Mognetti T (2010) Value of PETFDG in primary breast cancer based on histopathological and
immunohistochemical prognostic factors. Int J Clin Oncol 15 : 588-593
100 Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D (2010) Impaired Tolllike receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends
Immunol 31: 391-397
101 Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabe RR, Bhan MK,
Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings
JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L,
Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata
T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MM, Knoppers BM,
Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SO, Joly Y, Kato K,
Kennedy KL, Nicolas P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw
KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C,
Chin L, Clement B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN,
Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R,
Scarpa A, Shibata T, van d, V, Futreal PA, Aburatani H, Bayes M, Botwell DD,
Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, Lopez-Otin
C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS,
Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE,
Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell
PJ, Flicek P, Getz G, Guigo R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang
T, Jones SM, Li Q, Lopez-Bigas N, Luo R, Muthuswamy L, Ouellette BF,
Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP,
Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler
DA, Wu H, Zhao S, Zhou G, Stein LD, Guigo R, Hubbard TJ, Joly Y, Jones SM,
Kasprzyk A, Lathrop M, Lopez-Bigas N, Ouellette BF, Spellman PT, Teague JW,
Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SO, Futreal
PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ,
Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J,
Yung CK, Cross A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M,
Chalmers DR, Hasel KW, Joly Y, Kaan TS, Kennedy KL, Knoppers BM,
Lowrance WW, Masui T, Nicolas P, Rial-Sebbag E, Rodriguez LL, Vergely C,
Yoshida T, Grimmond SM, Biankin AV, Bowtell DD, Cloonan N, deFazio A,
Eshleman JR, Etemadmoghadam D, Gardiner BA, Kench JG, Scarpa A,
Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger
S, Tsao MS, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA,
Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu
Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li
X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I,
Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhlen M,
Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA,
Birney E, Borg A, Borresen-Dale AL, Caldas C, Foekens JA, Martin S, ReisFilho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van d, V, van't
13
Veer L, Calvo F (2010) International network of cancer genome projects. Nature
464: 993-998
102 Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, AbdelRahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R,
Jauch KW, Durr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W,
Blay JY, Hohenberger P (2010) Neo-adjuvant chemotherapy alone or with
regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised
phase 3 multicentre study. Lancet Oncol 11: 561-570
103 Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P,
Trassard M, Michels JJ, Blay JY, Coindre JM, Bui B (2010) Effect of adjuvant
chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a
multivariate analysis of the French Sarcoma Group Database. Ann Oncol 21 :
2436-2441
104 Joha S, Dauphin V, Lepretre F, Corm S, Nicolini FE, Roumier C, Nibourel O,
Grardel N, Maguer-Satta V, Idziorek T, Figeac M, Lai JL, Quesnel B, Etienne G,
Guilhot F, Lippert E, Preudhomme C, Roche-Lestienne C (2010) Genomic
characterization of Imatinib resistance in CD34(+) cell populations from chronic
myeloid leukaemia patients. Leuk Res
105 Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel
D, Vendrell JA, Dumontet C (2010) Sensitivity and gene expression profile of
fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. Cancer
Chemother Pharmacol
106 Julian-Reynier C, Bouhnik AD, Mouret-Fourme E, Gauthier-Villars M, Berthet P,
Lasset C, Fricker JP, Caron O, Gesta P, Luporsi E, Faivre L, Longy M, Gladieff
L, Frenay M, Dreyfus H, Sobol H, Vennin P, Nogues C (2010) Time to
prophylactic surgery in BRCA1/2 carriers depends on psychological and other
characteristics. Genet Med 12: 801-807
107 Kaufman B, Wu Y, Amonkar MM, Sherrill B, Bachelot T, Salazar V, Viens P,
Johnston S (2010) Impact of lapatinib monotherapy on QOL and pain symptoms
in patients with HER2+ relapsed or refractory inflammatory breast cancer. Curr
Med Res Opin 26: 1065-1073
108 Kieran MW, Walker D, Frappaz D, Prados M (2010) Brain tumors: From
childhood through adolescence into adulthood. J Clin Oncol 28 :4783-4789
109 Knaapen L, Cazeneuve H, Cambrosio A, Castel P, Fervers B (2010) Pragmatic
evidence and textual arrangements: a case study of French clinical cancer
guidelines. Soc Sci Med 71: 685-692
110 Kogan-Sakin I, Tabach Y, Buganim Y, Molchadsky A, Solomon H, Madar S,
Kamer I, Stambolsky P, Shelly A, Goldfinger N, Valsesia-Wittmann S, Puisieux
A, Zundelevich A, Gal-Yam EN, Avivi C, Barshack I, Brait M, Sidransky D,
14
Domany E, Rotter V (2010) Mutant p53(R175H) upregulates Twist1 expression
and promotes epithelial-mesenchymal transition in immortalized prostate cells.
Cell Death Differ
111 Lachenal F, Sebban C, Duruisseaux M, Biron P, Blay JY, Ghesquieres H (2010)
Influenza vaccination in patients with haematologic malignancies: analysis of
practices in 200 patients in a single center. Bull Cancer 97: E33-E36
112 Larouche JF, Berger F, Chassagne-Clement C, Ffrench M, Callet-Bauchu E,
Sebban C, Ghesquieres H, Broussais-Guillaumot F, Salles G, Coiffier B (2010)
Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma:
clinical characteristics and outcome. J Clin Oncol 28: 2094-2100
113 Le Cesne A, Blay JY, Bui BN, Bouche O, Adenis A, Domont J, Cioffi A, RayCoquard I, Lassau N, Bonvalot S, Moussy A, Kinet JP, Hermine O (2010) Phase
II study of oral masitinib mesilate in imatinib-naive patients with locally
advanced or metastatic gastro-intestinal stromal tumour (GIST). Eur J Cancer 46:
1344-1351
114 Le Cesne A, Ray-Coquard I, Bui BN, Adenis A, Rios M, Bertucci F, Duffaud F,
Chevreau C, Cupissol D, Cioffi A, Emile JF, Chabaud S, Perol D, Blay JY (2010)
Discontinuation of imatinib in patients with advanced gastrointestinal stromal
tumours after 3 years of treatment: an open-label multicentre randomised phase 3
trial. Lancet Oncol 11: 942-949
115 Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, Sentis S, Corbo L
(2010) Methylation, a key step for nongenomic estrogen signaling in breast
tumors. Steroids 75: 560-564
116 Liberelle B, Bartholin L, Boucher C, Murschel F, Jolicoeur M, Durocher Y,
Merzouki A, De CG (2010) New ELISA approach based on coiled-coil
interactions. J Immunol Methods 362: 161-167
117 Lurkin A, Ducimetiere F, Vince DR, Decouvelaere AV, Cellier D, Gilly FN,
Salameire D, Biron P, de Laroche G, Blay JY, Ray-Coquard I (2010)
Epidemiological evaluation of concordance between initial diagnosis and central
pathology review in a comprehensive and prospective series of sarcoma patients
in the Rhone-Alpes region. BMC Cancer 10: 150
118 Marabelle A, Bergeron C, Billaud G, Mekki Y, Girard S (2010) Hemophagocytic
syndrome revealing primary HHV-6 infection. J Pediatr 157: 511
119 Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A,
Fedeli U, Frasson A, Spolaore P, Rossi CR (2010) A European project on
incidence, treatment, and outcome of sarcoma. BMC Public Health 10: 188
120 Maucort-Boulch D, Baron MH, Pommier P, Weber DC, Mizoe JE, Rochat J,
Boissel JP, Balosso J, Tsujii H, Amsallem E (2010) Rationale for carbon ion
15
therapy in high-grade glioma based on a review and a meta-analysis of neutron
beam trials. Cancer Radiother 14: 34-41
121 Mazeron R, Etienne-Mastroianni B, Perol D, Arpin D, Vincent M, Falchero L,
Martel-Lafay I, Carrie C, Claude L (2010) Predictive factors of late radiation
fibrosis: a prospective study in non-small cell lung cancer. Int J Radiat Oncol
Biol Phys 77: 38-43
122 McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C (2010)
Outcomes in paediatric metastatic rhabdomyosarcoma: results of The
International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J
Cancer 46: 1588-1595
123 Mehlen P, Guenebeaud C (2010) Netrin-1 and its dependence receptors as original
targets for cancer therapy. Curr Opin Oncol 22: 46-54
124 Mestrallet G, Bertholet-Thomas A, Ranchin B, Bouvier R, Frappaz D, Cochat P
(2010) Recurrence of a dysgerminoma in Frasier syndrome. Pediatr Transplant
125 Monges G, Bisot-Locard S, Blay JY, Bouvier AM, Urbieta M, Coindre JM,
Scoazec JY (2010) The estimated incidence of gastrointestinal stromal tumors in
France. Results of PROGIST study conducted among pathologists. Bull Cancer
97: E16-E22
126 Morello LG, Hesling C, Coltri PP, Castilho BA, Rimokh R, Zanchin NI (2010)
The NIP7 protein is required for accurate pre-rRNA processing in human cells.
Nucleic Acids Res
127 Morschhauser F, Mounier N, Sebban C, Brice P, Solal-Celigny P, Tilly H,
Feugier P, Ferme C, Copin MC, Lamy T (2010) Efficacy and safety of the
combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive,
recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a
multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte
(GELA) and Groupe Ouest Est des Leucemies et Autres Maladies du Sang
(GOELAMS). Cancer 116: 4299-4308
128 N'djin WA, Melodelima D, Parmentier H, Rivoire M, Chapelon JY (2010) In vivo
preclinical evaluation of the accuracy of toroidal-shaped HIFU treatments using a
tumor-mimic model. Phys Med Biol 55: 2137-2154
129 Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, Sartor
C, Hogendoorn PC, Sciot R, Van Glabbeke M, Verweij J, Blay JY, Hohenberger
P, Flanagan A, Dei Tos AP (2010) DOG1 and CD117 are the antibodies of choice
in the diagnosis of gastrointestinal stromal tumours. Histopathology 57: 259-270
130 Pain S, Dezutter C, Reymermier C, Vogelgesang B, Delay E, Andre V (2010)
Age-related changes in pro-opiomelanocortin (POMC) and related receptors in
human epidermis. Int J Cosmet Sci 32: 266-275
16
131 Paradisi A, Mehlen P (2010) Netrin-1, a missing link between chronic
inflammation and tumor progression. Cell Cycle 9:
132 Paris M, Chaux-Bodard AG, Gourmet R, Fortin T (2010) Guided implant surgery
on oral cancer patients: in vitro study. Int J Comput Assist Radiol Surg
133 Pecorelli S, Ray-Coquard I, Tredan O, Colombo N, Parma G, Tisi G, Katsaros D,
Lhomme C, Lissoni AA, Vermorken JB, du BA, Poveda A, Frigerio L, Barbieri
P, Carminati P, Brienza S, Guastalla JP (2010) Phase II of oral gimatecan in
patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer,
previously treated with platinum and taxanes. Ann Oncol 21: 759-765
134 Penel N, Delord JP, Bonneterre ME, Bachelot T, Ray-Coquard I, Blay JY, Pascal
LB, Borel C, Filleron T, Adenis A, Bonneterre J (2010) Development and
validation of a model that predicts early death among cancer patients
participating in phase I clinical trials investigating cytotoxics. Invest New Drugs
28: 76-82
135 Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C,
Chevreau C, Cupissol D, Chabaud S, Jimenez M, Duffaud F, Piperno-Neumann
S, Mignot L, Blay JY (2010) Imatinib for progressive and recurrent aggressive
fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II
trial with a long-term follow-up. Ann Oncol
136 Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, Demaria O,
Viaud N, Gauthier L, Blery M, Bonnefoy-Berard N, Morel Y, Tschopp J,
Alexopoulou L, Trinchieri G, Paturel C, Caux C (2010) TLR3 and Rig-like
receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are
both mandatory for production of IFN-gamma in response to double-stranded
RNA. J Immunol 185: 2080-2088
137 Petroianu A, da Silva RG, Nascimento C, V, Alberti LR, da Silva MG (2010)
Effect of spleen surgeries on Escherichia coli distribution on the mononuclear
phagocytic system. Int J Surg 8: 48-51
138 Peyre M, Cartalat-Carel S, Meyronet D, Ricard D, Jouvet A, Pallud J, Mokhtari
K, Guyotat J, Jouanneau E, Sunyach MP, Frappaz D, Honnorat J, Ducray F
(2010) Prolonged response without prolonged chemotherapy: a lesson from PCV
chemotherapy in low-grade gliomas. Neuro Oncol 12: 1078-1082
139 Pomel C, Ferron G, Lorimier G, Rey A, Lhomme C, Classe JM, Bereder JM,
Quenet F, Meeus P, Marchal F, Morice P, Elias D (2010) Hyperthermic intraperitoneal chemotherapy using oxaliplatin as consolidation therapy for advanced
epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial.
CHIPOVAC study. Eur J Surg Oncol 36: 589-593
140 Pommier P, Dussart S, Girinsky T, Chabaud S, Lagrange JL, Nguyen TD,
Beckendorff V, D'Hombres A, Artignan X, Bondiau PY, Carrie C, Giammarile F
17
(2010) Impact of 18F-Fluoro-2-deoxyglucose Positron Emission Tomography on
Treatment Strategy and Radiotherapy Planning for Stage I-II Hodgkin Disease: A
Prospective Multicenter Study. Int J Radiat Oncol Biol Phys
141 Pommier P, Lievens Y, Feschet F, Borras JM, Baron MH, Shtiliyanova A, PijlsJohannesma M (2010) Simulating demand for innovative radiotherapies: an
illustrative model based on carbon ion and proton radiotherapy. Radiother Oncol
96: 243-249
142 Pommier P, Touboul E, Chabaud S, Dussart S, Le Pechoux C, Giammarile F,
Carrie C (2010) Impact of (18)F-FDG PET on treatment strategy and 3D
radiotherapy planning in non-small cell lung cancer: A prospective multicenter
study. AJR Am J Roentgenol 195: 350-355
143 Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, Traversier
S, Vittot M, Simon M, Gekiere JP, Meuric J, Serot F, Falewee MN, Rodrigues I,
Senesse P, Vasson MP, Chelle F, Maget B, Antoun S, Bachmann P (2010)
Prevalence, risk factors and clinical implications of malnutrition in French
Comprehensive Cancer Centres. Br J Cancer 102: 966-971
144 Ravaud A, de la Fouchardiere C, Asselineau J, Delord JP, Do CC, Niccoli P,
Rodien P, Klein M, Catargi B (2010) Efficacy of sunitinib in advanced medullary
thyroid carcinoma: intermediate results of phase II THYSU. Oncologist 15: 212213
145 Ray-Coquard I, Weber B, Lotz JP, Tournigand C, Provencal J, Mayeur D,
Treilleux I, Paraiso D, Duvillard P, Pujade-Lauraine E (2010) Management of
rare ovarian cancers: the experience of the French website "Observatory for rare
malignant tumours of the ovaries" by the GINECO group: interim analysis of the
first 100 patients. Gynecol Oncol 119: 53-59
146 Reichardt P, Blay JY, Mehren M (2010) Towards global consensus in the
treatment of gastrointestinal stromal tumor. Expert Rev Anticancer Ther 10: 221232
147 Renneville A, Kaltenbach S, Clappier E, Collette S, Micol JB, Nelken B, Lepelley
P, Dastugue N, Benoit Y, Bertrand Y, Preudhomme C, Cave H (2010) Wilms
tumor 1 (WT1) gene mutations in pediatric T-cell malignancies. Leukemia 24:
476-480
148 Rolland D, Ribrag V, Haioun C, Ghesquieres H, Jardin F, Bouabdallah R, Franchi
P, Briere J, De Kerviler E, Chassagne-Clement C, Raponi M, Houlgatte R, Jais
JP, Thieblemont C (2010) Phase II trial and prediction of response of single agent
tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe
d'Etude des Lymphomes de l'Adulte trial. Cancer Chemother Pharmacol 65: 781790
18
149 Rouleau E, Lefol C, Moncoutier V, Castera L, Houdayer C, Caputo S, Bieche I,
Buisson M, Mazoyer S, Stoppa-Lyonnet D, Nogues C, Lidereau R (2010) A
missense variant within BRCA1 exon 23 causing exon skipping. Cancer Genet
Cytogenet 202: 144-146
150 Rubie H, Geoerger B, Frappaz D, Schmitt A, Leblond P, Ndiaye A, Aerts I, Le
Deley MC, Gentet JC, Paci A, Chastagner P, Dias N, Djafari L, Pasquet M,
Chatelut E, Landman-Parker J, Corradini N, Vassal G (2010) Phase I study of
topotecan in combination with temozolomide (TOTEM) in relapsed or refractory
paediatric solid tumours. Eur J Cancer 46: 2763-2770
151 Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y, Lambilliotte A,
Robert A, Michel G, Margueritte G, Tandonnet J, Mechinaud F, Bordigoni P,
Hemon D, Clavel J (2010) Childhood Acute Leukemia, Early Common
Infections, and Allergy: The ESCALE Study. Am J Epidemiol 172 : 1015-1027
152 Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, Benard J,
Forget S, Blanchard C, Domont J, Bonvalot S, Guillou L, Leroux A, MechineNeuville A, Schoffski P, Lae M, Collin F, Verola O, Carbonnelle A, Vescovo L,
Bui B, Brouste V, Sobol H, Aurias A, Coindre JM (2010) Molecular
characterization by array comparative genomic hybridization and DNA
sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49: 560-568
153 Sarrut D, Vandemeulebroucke J (2010) B-LUT: Fast and low memory B-spline
image interpolation. Comput Methods Programs Biomed 99: 172-178
154 Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, Klijanienko J, Couturier J,
Pierron G, Mosseri V, Valent A, Auger N, Plantaz D, Rubie H, Valteau-Couanet
D, Bourdeaut F, Combaret V, Bergeron C, Michon J, Delattre O (2010)
Accumulation of segmental alterations determines progression in neuroblastoma.
J Clin Oncol 28: 3122-3130
155 Schoffski P, Blay JY, De Greve J, Brain E, Machiels JP, Soria JC, Sleijfer S,
Wolter P, Ray-Coquard I, Fontaine C, Munzert G, Fritsch H, Hanft G, Aerts C,
Rapion J, Allgeier A, Bogaerts J, Lacombe D (2010) Multicentric parallel phase
II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head
and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and
melanoma. The first protocol of the European Organization for Research and
Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI). Eur J
Cancer 46: 2206-2215
156 Schoffski P, Reichardt P, Blay JY, Dumez H, Morgan JA, Ray-Coquard I,
Hollaender N, Jappe A, Demetri GD (2010) A phase I-II study of everolimus
(RAD001) in combination with imatinib in patients with imatinib-resistant
gastrointestinal stromal tumors. Ann Oncol 21: 1990-1998
157 Sinna R, Delay E, Garson S, Delaporte T, Toussoun G (2010) Breast fat grafting
(lipomodelling) after extended latissimus dorsi flap breast reconstruction: A
19
preliminary report of 200 consecutive cases. J Plast Reconstr Aesthet Surg 63 :
1769-1777
158 Sinna R, Garson S, Delay E (2010) Lipomodelling or lipomodeling? Breast 19:
434
159 Sinna R, Perignon D, Qassemyar Q, Benhaim T, Dodreanu CN, Berna P, Delay E
(2010) Case report. A double thoracodorsal artery perforator flap technique for
the treatment of pectus excavatum. Eplasty 10: e34
160 Sinna R, Qassemyar Q, Garson S, Delay E (2010) Fat injection for overcorrected
gynaecomastia. J Plast Reconstr Aesthet Surg 63 : 2196-2197
161 Sleijfer S, Ouali M, Van Glabbeke M, Krarup-Hansen A, Rodenhuis S, Le Cesne
A, Hogendoorn PC, Verweij J, Blay JY (2010) Prognostic and predictive factors
for outcome to first-line ifosfamide-containing chemotherapy for adult patients
with advanced soft tissue sarcomas: an exploratory, retrospective analysis on
large series from the European Organization for Research and Treatment of
Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Eur J Cancer
46: 72-83
162 Sudour H, Chastagner P, Claude L, Desandes E, Klein M, Carrie C, Bernier V
(2010) Fertility and pregnancy outcome after abdominal irradiation that included
or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys
76: 867-873
163 Terret C, Albrand G, Moncenix G, Droz JP (2010) Karnofsky Performance Scale
(KPS) or Physical Performance Test (PPT)? That is the question. Crit Rev Oncol
Hematol
164 Terret C, Droz JP (2010) Editorial. The perception and dissemination of geriatric
oncology. Crit Rev Oncol Hematol 75: 43-46
165 Terret C, Perol D, Albrand G, Droz JP (2010) Quality of life in geriatric
oncology-An evaluation of standard questionnaires in elderly men with urological
malignancies. Crit Rev Oncol Hematol
166 Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavailles V (2010)
Protein arginine methylation in estrogen signaling and estrogen-related cancers.
Trends Endocrinol Metab 21: 181-189
167 Thibert C, Fombonne J (2010) Dependence receptors: Mechanisms of an
announced death. Cell Cycle 9:
168 Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M,
Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with
giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11: 275280
20
169 Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C,
Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C,
Micheau M, Bernaudin F, Leblanc T, Lutz L, Galacteros F, Simeoni MC, Badens
C (2010) Complications and treatment of patients with beta-thalassemia in
France: results of the National Registry. Haematologica 95: 724-729
170 Tredan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, Bachelot T,
Guastalla JP, Lallemand Y, Faure C, Perol D, Bachmann P (2010) Body weight
change in women receiving adjuvant chemotherapy for breast cancer: a French
prospective study. Clin Nutr 29: 187-191
171 Vincent DF, Kaniewski B, Powers SE, Havenar-Daughton C, Marie JC, Wotton
D, Bartholin L (2010) A rapid strategy to detect the recombined allele in LSLTbetaRICA transgenic mice. Genesis 48: 559-562
172 Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L,
Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D,
Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Houdayer C, Hogervorst FB,
Hooning MJ, Ligtenberg MJ, Spurdle A, Chenevix-Trench G, Schmutzler RK,
Wappenschmidt B, Engel C, Meindl A, Domchek SM, Nathanson KL, Rebbeck
TR, Singer CF, Gschwantler-Kaulich D, Dressler C, Fink A, Szabo CI, Zikan M,
Foretova L, Claes K, Thomas G, Hoover RN, Hunter DJ, Chanock SJ, Easton DF,
Antoniou AC, Couch FJ (2010) Common variants associated with breast cancer
in genome-wide association studies are modifiers of breast cancer risk in BRCA1
and BRCA2 mutation carriers. Hum Mol Genet 19: 2886-2897
173 Watkin E, Devouassoux-Shisheboran M, Pedeutour F, Lagarde P, Salle M,
Ranchere-Vince D, Baulieux J, Barnoud R (2010) A First Reported Case of
Dedifferentiated Liposarcoma of the Esophagus with Molecular Diagnosis. J
Gastrointest Cancer
174 You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M,
Chabaud S, Coquelin H, Flechon A (2010) Predictive value of modeled
AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor
marker decline in patients with nonseminomatous germ cell tumor. Urology 76:
423-429
175 You B, Pollet-Villard M, Fronton L, Labrousse C, Schott AM, Hajri T, Girard P,
Freyer G, Tod M, Tranchand B, Colomban O, Ribba B, Raudrant D, Massardier
J, Chabaud S, Golfier F (2010) Predictive values of hCG clearance for risk of
methotrexate resistance in low-risk gestational trophoblastic neoplasias. Ann
Oncol 21: 1643-1650
176 Zacharoulis S, Ashley S, Moreno L, Gentet JC, Massimino M, Frappaz D (2010)
Treatment and outcome of children with relapsed ependymoma: a multiinstitutional retrospective analysis. Childs Nerv Syst 26: 905-911
21
177 Zahra N, Frisson T, Grevillot L, Lautesse P, Sarrut D (2010) Influence of Geant4
parameters on dose distribution and computation time for carbon ion therapy
simulation. Phys Med 26: 202-208
178 Zane L, Sibon D, Jeannin L, Zandecki M, Delfau-Larue MH, Gessain A, Gout O,
Pinatel C, Lancon A, Mortreux F, Wattel E (2010) Tax gene expression and cell
cycling but not cell death are selected during HTLV-1 infection in vivo.
Retrovirology 7: 17
179 Zane L, Sibon D, Legras C, Lachuer J, Wierinckx A, Mehlen P, Delfau-Larue
MH, Gessain A, Gout O, Pinatel C, Lancon A, Mortreux F, Wattel E (2010)
Clonal expansion of HTLV-1 positive CD8(+) cells relies on cIAP-2 but not on cFLIP expression. Virology 407 : 341-351
180 Zeinyeh W, Alameh G, Radix S, Grenot C, Dumontet C, Walchshofer N (2010)
Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent
inhibitors of P-glycoprotein-mediated multidrug efflux. Bioorg Med Chem Lett
20: 3165-3168
22